THE ACADEMIC CONSORTIUM
The ReIMAGINE consortium comprises many of the world’s globally pre-eminent thought leaders in the area of prostate cancer diagnosis (Ahmed, Moore, and Emberton), imaging (Punwani), molecular characterisation (Attard and Whitaker), clinical epidemiology (Van Hemelrijck), advanced analytics (Coolen) and statistics (Brown), and global consortia/consensus development (Moore).
PROFESSOR MARK EMBERTON
Professor of Interventional Oncology at UCL. Mark will lead WS7, project management/commercial. Project Management (PM) will be informed at every stage by real-time inputs. All work strands will be advanced & coordinated by means of our PM system that will also serve our numerous commercial partners.